Nextage Therapeutics Ltd (TASE: NXTG)
Health Care · Biotechnology · IL
₪0.39
+2.09% today · -56.9% 1Y
Nextage Therapeutics Ltd (TASE: NXTG) operates in the Biotechnology industry within the Health Care sector. The company is valued at $4.45M and employs 31 people.
Over the last twelve months the share price has lost 56.9%, trading between 0.06 and 1.00.
Tweenvest scores Nextage Therapeutics Ltd across four factors: quality 23/100, value 60/100. Its strongest factor is value.
NXTG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.45M
- Revenue (TTM)
- $72.12K
- P/E
- 2.43
- EPS
- 0.16
- Dividend yield
- —
- Beta (5Y)
- 0.17
- 52-week high
- ₪1.00
- 52-week low
- ₪0.06
- Avg volume (3M)
- —
- Shares outstanding
- 33.70M
- Employees
- 31
- Next earnings
- —
About Nextage Therapeutics Ltd
Nextage Therapeutics Ltd, an Israeli company operating from Ness Ziona, focuses on the creation of cannabinoid-derived products.
- ISIN
- IL0004330119
- Founded
- 1982
- Listed since
- Aug 12, 2002
- Exchange
- The Tel-Aviv Stock Exchange
- Currency
- ILS
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $260.86 | -1.85% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $439.88 | -0.53% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.44 | -0.22% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $550.80 | -0.37% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $817.92 | -1.88% |
| argenx SEENXTBR: ARGX | $64.17B | €900.00 | +2.37% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $147.63 | -7.05% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.